FindTrial
Sign In

Compassionate Use of Vidutolimod

Status
NO_LONGER_AVAILABLE
Phases
Unknown
Study type
Expanded Access
Source
ClinicalTrials.gov
Registry ID
NCT06063746
Enrollment
Unknown
Registered
2023-10-03
Start date
Unknown
Completion date
Unknown
Last updated
2026-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Refractory Melanoma

Brief summary

Provide Compassionate Use of Vidutolimob

Detailed description

Compassionate use is only available to patients who transitioned from a previous vidutolimod (CMP-001) study.

Interventions

DRUGVidutolimod

Sponsors

Regeneron Pharmaceuticals
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
ALL

Inclusion criteria

\-

Exclusion criteria

\-

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026